Diode Laser versus Trichloroacetic Acid Local Cauterization for Treatment of Anterior Epistaxis in Children

Abdulhussein Kareem Jwery; Ali Abed Mohammed; Mohammed Radef Dawood

doi:10.54133/ajms.v10i1.2635

Authors

Abdulhussein Kareem Jwery Otorhinolaryngology Department, College of Medicine, Mustansiriyah University, Baghdad, Iraq https://orcid.org/0000-0002-6776-8212
Ali Abed Mohammed Otorhinolaryngology Department, College of Medicine, Mustansiriyah University, Baghdad, Iraq https://orcid.org/0000-0002-6721-6063
Mohammed Radef Dawood Otorhinolaryngology Department, College of Medicine, Mustansiriyah University, Baghdad, Iraq https://orcid.org/0000-0002-2991-8056

DOI:

https://doi.org/10.54133/ajms.v10i1.2635

Keywords:

Epistaxis, Diode laser, Trichloroacetic acid

Abstract

Background: Epistaxis is one of the most common emergencies detected in the otorhinolaryngology unit. Although it's mostly benign, sometimes it can lead to life-threatening conditions; however, there was no specific local cauterization available for the controlling of little-area anterior epistaxis in children. Objective: To evaluate the outcome of diode laser versus trichloroacetic acid in local cauterization of anterior epistaxis in children. Methods: A prospective randomized comparative study, conducted on 60 children with anterior epistaxis, where the bleeding point was identified in a little area of the nasal septum at the otorhinolaryngology unit, was divided into 2 groups: Group “A” included 30 children treated by diode laser, and group “B” included 30 children treated by trichloroacetic acid (TAC) in a 1-year study duration. Results: The mean age was 10.5±2.2 years in group A and 10.1±2.5 years in group B, with bleeding according to age groups (p>0.05). Most of the children were 10 years old, being 26.66% in group A and 23.33% in group B. Males were 68.33%, and females were 31.67%. The efficacy of local cauterization (yes/no) was significant for males and females (p<0.05). The recurrence rate of epistaxis after 3 months of follow-up in group A was 16.7%, and in group B, 66.7% (p=0.0001). Conclusions: Diode laser local cauterization had significantly better results in the management of pediatric anterior epistaxis regarding bleeding site in comparison with that of trichloroacetic acid.

Downloads

Download data is not yet available.

References

Douglas R, Wormald PJ. Update on epistaxis. Curr Opin Otolaryngol Head Neck Surg. 2007;15(3):180-183. doi: 10.1097/MOO.0b013e32814b06ed. DOI: https://doi.org/10.1097/MOO.0b013e32814b06ed

Walker TW, Macfarlane TV, McGarry GW. The epidemiology and chronobiology of epistaxis: an investigation of Scottish hospital admissions 1995-2004. Clin Otolaryngol. 2007;32(5):361-365. doi: 10.1111/j.1749-4486.2007.01530.x. DOI: https://doi.org/10.1111/j.1749-4486.2007.01530.x

Hill CS, Hughes O. Update on management of epistaxis. West London Med J. 2009;1(1):33–42. http://www.ubplj.org/index.php/wlmj/article/viewFile/52/163. DOI: https://doi.org/10.1177/0306422013479093

Randall DA, Freeman SB. Management of anterior and posterior epistaxis. Am Fam Physician. 1991;43(6):2007-2014. PMID: 2042544..

Swain SK, Mallik KC. Ear, nose, and throat foreign bodies in pediatric age. Med J Babylon. 2020;17(3):238-243. doi: 10.4103/MJBL.MJBL_37_20. DOI: https://doi.org/10.4103/MJBL.MJBL_37_20

Yan T, Goldman RD. Recurrent epistaxis in children. Can Fam Physician. 2021;67(6):427-429. doi: 10.46747/cfp.6706427. DOI: https://doi.org/10.46747/cfp.6706427

Al-Maaroof ZW. Factor VIII intron 22 inversion mutation in samples of Iraqi patients with hemophilia A. Med J Babylon. 2024;21(2):399-404. doi: 10.4103/MJBL.MJBL_1361_23. DOI: https://doi.org/10.4103/MJBL.MJBL_1361_23

Shukr IA, Omar HW, Saber, Ihsan SPA, Narren T. On-demand versus prophylactic therapy with factor VIII concentrates in patients with hemophilia A: Differences in efficacy and quality of life: A multicenter study. Med J Babylon. 2023;20(Sup1):S63-S68. doi: 10.4103/MJBL.MJBL_1_23. DOI: https://doi.org/10.4103/MJBL.MJBL_1_23

Pallin DJ, Chng YM, McKay MP, Emond JA, Pelletier AJ, Camargo CA. Epidemiology of epistaxis in US emergency departments, 1992 to 2001. Ann Emerg Med. 2005;46(1):77-81. doi: 10.1016/j.annemergmed.2004.12.014. DOI: https://doi.org/10.1016/j.annemergmed.2004.12.014

Mgbor NC. Epistaxis in Enugu: a 9-year review. Nig J Otorhinolaryngol. 2004;1(2):11–14. doi: 10.4314/njorl.v1i1.32434.

Soyka MB, Nikolaou G, Rufibach K, Holzmann D. On the effectiveness of treatment options in epistaxis: an analysis of 678 interventions. Rhinology. 2011;49(4):474-478. doi: 10.4193/Rhino10.313. DOI: https://doi.org/10.4193/Rhino10.313

Abiri A, Goshtasbi K, Maducdoc M, Sahyouni R, Wang MB, Kuan EC. Laser-assisted control of epistaxis in hereditary hemorrhagic telangiectasia: A systematic review. Lasers Surg Med. 2020;52(4):293-300. doi: 10.1002/lsm.23147. DOI: https://doi.org/10.1002/lsm.23147

Hopf M, Jürgen UG, Rohde E, Müller G, Scheller E, Scherer H. Endoscopically controlled laser therapy of recurrent epistaxis with the 940 nm diode laser Med Laser Appl. 2002;17(3):231-241. doi: 10.1078/1615-1615-00066. DOI: https://doi.org/10.1078/1615-1615-00066

Yaniv D, Alkan U, Yaniv E, Bumbuluț C, Rath-Wolfson L. Laser treatment of epistaxis and oral bleeding in hereditary hemorrhagic telangiectasia. Int J Otolaryngol Head Neck Surg. 2019;8(5):180-190. doi: 10.4236/ijohns.2019.85020. DOI: https://doi.org/10.4236/ijohns.2019.85020

Karapantzos I, Tsimpiris N, Goulis DG, Van Hoecke H, Van Cauwenberge P, Danielides V. Management of epistaxis in hereditary hemorrhagic telangiectasia by Nd:YAG laser and quality of life assessment using the HR-QoL questionnaire. Eur Arch Otorhinolaryngol. 2005;262(10):830-833. doi: 10.1007/s00405-004-0911-0. DOI: https://doi.org/10.1007/s00405-004-0911-0

Kuan EC, Peng KA, Thompson CF, Suh JD, Wang MB. Sinonasal quality of life outcomes following laser treatment of epistaxis related to hereditary hemorrhagic telangiectasia. Lasers Med Sci. 2017;32(3):527-531. doi: 10.1007/s10103-017-2144-7. DOI: https://doi.org/10.1007/s10103-017-2144-7

Ikram T, Asim MU, Sundas Masood S, Fatima A, Akash H, et al. Efficacy of chemical and electrical cautery (Comparison) in management of anterior epistaxis. J Raw Med Coll. 2022;1(1):6-10. doi: 10.37939/jrmc.v1i1.1807. DOI: https://doi.org/10.37939/jrmc.v1i1.1807

Ando Y, Iimura J, Arai S, Arai C, Komori M, Tsuyumu M, et al. Risk factors for recurrent epistaxis: importance of initial treatment. Auris Nasus Larynx. 2014;41(1):41-45. doi: 10.1016/j.anl.2013.05.004. DOI: https://doi.org/10.1016/j.anl.2013.05.004

Kucik CJ, Clenney T. Management of epistaxis. Am Fam Physician. 2005;71(2):305-311. PMID: 15686301.

Mohammed AA, Jwery AK, Dawood MR. High intensity focused ultrasound versus diode laser for treatment of inferior turbinate hypertrophy. Eur J Rhinol Allergy. 2024;7(3):89-94. doi: 10.5152/ejra.2024.24154. DOI: https://doi.org/10.5152/ejra.2024.24154

Felek SA, Celik H, Islam A, Demirci M. Bilateral simultaneous nasal septal cauterization in children with recurrent epistaxis. Int J Pediatr Otorhinolaryngol. 2009;73(10):1390-1393. doi: 10.1016/j.ijporl.2009.06.023. DOI: https://doi.org/10.1016/j.ijporl.2009.06.023

Parajuli R. Evaluation of etiology and treatment methods for epistaxis: A review at a tertiary care hospital in Central Nepal. Int J Otolaryngol. 2015;2015:283854. doi: 10.1155/2015/283854. DOI: https://doi.org/10.1155/2015/283854

Das D, Saha J, Ghosh AK, Maitra T. Management of epistaxis in a rural based tertiary care hospital: Our experience. IOSR J Dent Med Sci. 2017;16(11):16-21. doi: 10.9790/0853-1611121621.